{"meta":{"query_hash":"fddd65d259ba","filters":{"venue":"Journal of Market Access & Health Policy"},"cohort_total":11,"direct_labels_cover":0,"predictions_cover":11,"exported":11,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/fddd65d259ba","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Market+Access+%26+Health+Policy"},"results":[{"id":"W2488011870","doi":"10.3402/jmahp.v4.31463","title":"Challenges in striving to simultaneously achieve multiple resource allocation goals: the pan-Canadian Oncology Drug Review (pCODR) example","year":2016,"lang":"en","type":"article","venue":"Journal of Market Access & Health Policy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"CLARITY; Prioritization; Order (exchange); Plan (archaeology); Resource allocation; Health care; Resource (disambiguation); Cancer drugs; Perspective (graphical); Business; Management science; Process management; Computer science; Risk analysis (engineering); Public relations; Political science; Medicine; Drug; Economics; Pharmacology; Finance","score_opus":0.4646607408831695,"score_gpt":0.5042006085953252,"score_spread":0.03953986771215573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488011870","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011857735,0.06552963,0.014020215,0.6403048,0.0015997728,0.0004064423,0.0007728198,0.00015932888,0.2653492],"genre_scores_gemma":[0.6073323,0.07187708,0.112512216,0.16151643,0.001695847,0.00063955836,0.0007172058,0.00024373463,0.04346566],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.95066965,0.021292474,0.0014713175,0.001920352,0.017386192,0.007260023],"domain_scores_gemma":[0.9417628,0.024532218,0.0018976941,0.001334909,0.024948962,0.005523466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.034867678,0.0012512393,0.0010655376,0.004729516,0.012289396,0.014565355,0.0033347416,0.008267304,0.0033003858],"category_scores_gemma":[0.054819614,0.0005676773,0.0014787904,0.009708059,0.00871596,0.00543466,0.0040358803,0.006903276,0.00046518177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113363145,0.00007138795,0.0027461972,0.001183129,0.00016533755,0.000702081,0.002009886,0.0075474414,0.00046429137,0.74736077,0.17722596,0.06041029],"study_design_scores_gemma":[0.00018616168,0.00007458511,0.0072840704,0.0017028893,0.00029830114,0.00056311255,0.003938676,0.0077142753,0.0005857606,0.17395967,0.8034451,0.00024730837],"about_ca_topic_score_codex":0.8907251,"about_ca_topic_score_gemma":0.94889075,"teacher_disagreement_score":0.88883436,"about_ca_system_score_codex":0.11116567,"about_ca_system_score_gemma":0.241675,"threshold_uncertainty_score":0.8065672},"labels":[],"label_agreement":null},{"id":"W2551027286","doi":"10.3402/jmahp.v4.33248","title":"A training paradigm to enhance performance and safe use of an innovative neuroendovascular device","year":2016,"lang":"en","type":"article","venue":"Journal of Market Access & Health Policy","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of British Columbia","funders":"","keywords":"Computer science; Training (meteorology); Complement (music); Selection (genetic algorithm); Medical physics; Medicine; Artificial intelligence","score_opus":0.09066446744580157,"score_gpt":0.4091008253124968,"score_spread":0.3184363578666952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551027286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4662026,0.0011247096,0.32078117,0.030000044,0.0011792753,0.0064864163,0.00016538192,0.0014402419,0.17262019],"genre_scores_gemma":[0.52345604,0.0014011059,0.43945533,0.0047730827,0.00036777725,0.004426559,0.00012711703,0.00012068023,0.025872402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997661,0.0010130928,0.00010804809,0.00025365298,0.0007137018,0.0002505556],"domain_scores_gemma":[0.99708146,0.00075707637,0.0004539563,0.00027087197,0.0006565278,0.0007801251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039236676,0.00047093572,0.00020497994,0.0011319903,0.0012774592,0.0010862951,0.0013279964,0.0010468499,0.004878479],"category_scores_gemma":[0.0056411168,0.000194623,0.00031780376,0.00029341172,0.0012354613,0.0014577028,0.0028325554,0.0016392659,0.001833257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004019771,0.01715155,0.010564242,0.0010140691,0.000035652258,0.0004266982,0.011326845,0.0030515955,0.03220173,0.049593,0.022323359,0.85190934],"study_design_scores_gemma":[0.0018383822,0.03205862,0.17800365,0.0038717992,0.00016909774,0.0059307516,0.015830666,0.042614456,0.041862324,0.10156737,0.5757066,0.0005462469],"about_ca_topic_score_codex":0.0005983012,"about_ca_topic_score_gemma":0.0015198773,"teacher_disagreement_score":0.004878479,"about_ca_system_score_codex":0.0012839277,"about_ca_system_score_gemma":0.0033237105,"threshold_uncertainty_score":0.020750582},"labels":[],"label_agreement":null},{"id":"W2593404984","doi":"10.1080/20016689.2017.1283106","title":"Role of preliminary registry data in development of a clinical trial for an innovative device: a small but integral piece of a health policy initiative","year":2017,"lang":"en","type":"article","venue":"Journal of Market Access & Health Policy","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Clinical trial; Medical physics; Health care; Data collection; Medicine; Process management; Risk analysis (engineering); Computer science; Business; Political science","score_opus":0.3481206429235412,"score_gpt":0.5495211997656897,"score_spread":0.20140055684214847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593404984","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028424002,0.013558994,0.19139811,0.683283,0.0099495975,0.016611576,0.0020325915,0.0014365395,0.05330563],"genre_scores_gemma":[0.3574507,0.007553505,0.4592251,0.13834676,0.00774204,0.021187825,0.0022084347,0.000710911,0.005574717],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.35465834,0.52903855,0.049936123,0.013426505,0.046198077,0.0067424783],"domain_scores_gemma":[0.061189216,0.79039234,0.028576959,0.05642382,0.051863782,0.011553884],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.7878047,0.0019338313,0.0044518295,0.008666763,0.005271078,0.030712454,0.010651356,0.019254958,0.007701606],"category_scores_gemma":[0.69733727,0.0030466034,0.0039209924,0.0072677196,0.013498981,0.031054175,0.013227527,0.027522977,0.0024223998],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005354856,0.0035256494,0.04334318,0.0056583127,0.0016545058,0.0017165756,0.007978857,0.012657108,0.0045988224,0.36066085,0.098932356,0.45391893],"study_design_scores_gemma":[0.0064180917,0.011142669,0.03531156,0.024206778,0.0019758474,0.001523881,0.0052102916,0.026056048,0.009869509,0.22805142,0.64834875,0.0018850918],"about_ca_topic_score_codex":0.0056850873,"about_ca_topic_score_gemma":0.004077573,"teacher_disagreement_score":0.7878047,"about_ca_system_score_codex":0.010262633,"about_ca_system_score_gemma":0.103079826,"threshold_uncertainty_score":0.26167464},"labels":[],"label_agreement":null},{"id":"W2968568322","doi":"10.1080/20016689.2019.1650596","title":"Why “American Patients First” is likely to raise drug prices outside of the United States","year":2019,"lang":"en","type":"review","venue":"Journal of Market Access & Health Policy","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blueprint; Negotiation; Drug prices; Administration (probate law); International trade; Drug pricing; Food and drug administration; Political science; International economics; Business; Economics; Public economics; Law; Actuarial science; Management","score_opus":0.07185893170955603,"score_gpt":0.4186940409292448,"score_spread":0.34683510921968874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968568322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037377796,0.9897621,0.00006777946,0.0077795996,0.00030270775,0.0000056705812,0.000024374998,0.0000024291744,0.0016815156],"genre_scores_gemma":[0.009790564,0.985136,0.0001452242,0.0041768104,0.00039992857,0.0000135371265,0.00002768551,0.000002157325,0.0003081844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964636,0.0017557135,0.00046482394,0.000316271,0.00079669454,0.00020293683],"domain_scores_gemma":[0.98514706,0.010900948,0.0024717674,0.00015226868,0.0010818541,0.00024616404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004522849,0.00028306825,0.00083518535,0.0017489808,0.0004442082,0.0025652312,0.00073762255,0.0030311877,0.004735297],"category_scores_gemma":[0.017336499,0.00024120726,0.0009314056,0.0029034477,0.0014164472,0.0026814933,0.0005937345,0.0020386735,0.00066441094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022920703,0.00006738989,0.0032254688,0.089205556,0.00060738827,0.0006435572,0.0007599471,0.00027785226,0.0002757594,0.042675186,0.104701616,0.7573311],"study_design_scores_gemma":[0.000093876064,0.00012230607,0.008056193,0.10111175,0.0008428325,0.0029297187,0.0014610741,0.000165178,0.00043184185,0.013622833,0.8711064,0.0000559998],"about_ca_topic_score_codex":0.004291359,"about_ca_topic_score_gemma":0.007389697,"teacher_disagreement_score":0.004735297,"about_ca_system_score_codex":0.0016631095,"about_ca_system_score_gemma":0.0057785995,"threshold_uncertainty_score":0.023919404},"labels":[],"label_agreement":null},{"id":"W2999237747","doi":"10.1080/20016689.2020.1715536","title":"Outcomes-based reimbursement for gene therapies in practice: the experience of recently launched CAR-T cell therapies in major European countries","year":2020,"lang":"en","type":"article","venue":"Journal of Market Access & Health Policy","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Payment; European union; Business; Quarter (Canadian coin); Product (mathematics); Health care; European market; Medicine; Marketing; Finance; Economic growth; Economics; International trade; Geography","score_opus":0.0599014430613446,"score_gpt":0.43239230961009045,"score_spread":0.37249086654874586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999237747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.654324,0.10293046,0.0073975804,0.14016083,0.001385343,0.0002991582,0.0026813247,0.00014004871,0.090681374],"genre_scores_gemma":[0.9634977,0.017289154,0.0031125138,0.012286304,0.0004546054,0.000095336094,0.00078356377,0.000091582806,0.0023892114],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97916746,0.0129516795,0.0014264588,0.0010581756,0.0036094766,0.0017866892],"domain_scores_gemma":[0.9547789,0.025443798,0.006842478,0.0018787911,0.0056593297,0.0053967796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.042800017,0.00031770134,0.0005074247,0.000780697,0.00092134136,0.0054242103,0.00084152777,0.0021829356,0.004846771],"category_scores_gemma":[0.057620637,0.00020647896,0.000647913,0.0018208519,0.0032419625,0.002615843,0.0032162825,0.0023768095,0.00065501523],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028970272,0.0010419529,0.1433302,0.0036140522,0.00042302607,0.0039450643,0.029941197,0.005042225,0.001379929,0.066187955,0.10184922,0.64034814],"study_design_scores_gemma":[0.0007526919,0.0029225843,0.207503,0.010574173,0.00032216683,0.008188538,0.04309212,0.0023667547,0.002944985,0.01271849,0.70831513,0.00029931526],"about_ca_topic_score_codex":0.0048903967,"about_ca_topic_score_gemma":0.003065841,"teacher_disagreement_score":0.042800017,"about_ca_system_score_codex":0.0058388677,"about_ca_system_score_gemma":0.007830605,"threshold_uncertainty_score":0.22635084},"labels":[],"label_agreement":null},{"id":"W3193864401","doi":"10.1080/20016689.2021.1964791","title":"Accelerating patient access to oncology medicines with multiple indications in Europe","year":2021,"lang":"en","type":"review","venue":"Journal of Market Access & Health Policy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Reimbursement; Market access; Business; Product (mathematics); Process (computing); Medicine; Actuarial science; Operations management; Computer science; Economics; Health care; Economic growth","score_opus":0.5673573973348432,"score_gpt":0.5849998081847655,"score_spread":0.01764241084992224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193864401","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.311426,0.14273809,0.06752897,0.17590374,0.0027495867,0.00067207636,0.002047107,0.0011217901,0.2958126],"genre_scores_gemma":[0.8090413,0.043762036,0.07210714,0.058493856,0.0015401092,0.00028352902,0.0017600302,0.00024231212,0.012769677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98836726,0.004722355,0.0016134942,0.00091620436,0.0031902338,0.0011904844],"domain_scores_gemma":[0.9733815,0.011952214,0.0063710865,0.0017886362,0.004138534,0.0023679857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026654946,0.00030765566,0.0003963991,0.0013581831,0.0006102351,0.004485473,0.0012151605,0.0027204328,0.006796573],"category_scores_gemma":[0.029255126,0.00022734274,0.0018725671,0.0016063062,0.0013860917,0.0059753656,0.0048621497,0.002584829,0.0007044211],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007330695,0.00052081834,0.047103725,0.003663424,0.00053249643,0.0015561134,0.0019435954,0.008759101,0.004335038,0.17376153,0.05226755,0.70482355],"study_design_scores_gemma":[0.00035273965,0.0011367891,0.047666427,0.005276784,0.00034623008,0.0038772125,0.0014930981,0.0031525178,0.0064946786,0.030602248,0.8994798,0.00012155829],"about_ca_topic_score_codex":0.0022170637,"about_ca_topic_score_gemma":0.0015183879,"teacher_disagreement_score":0.026654946,"about_ca_system_score_codex":0.0033964526,"about_ca_system_score_gemma":0.0072391927,"threshold_uncertainty_score":0.14096648},"labels":[],"label_agreement":null},{"id":"W4398182533","doi":"10.3390/jmahp12020009","title":"Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance","year":2024,"lang":"en","type":"review","venue":"Journal of Market Access & Health Policy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Protocol (science); Health technology; Critical appraisal; Medicine; Business; Political science; Alternative medicine; Health care","score_opus":0.6991957781312884,"score_gpt":0.6739127582861535,"score_spread":0.025283019845134924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398182533","genre_codex":"review","genre_gemma":"review","domain_codex":"methods","domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006918283,0.694466,0.03206638,0.22982873,0.010648168,0.017033882,0.00071676244,0.00026397227,0.008057839],"genre_scores_gemma":[0.12619461,0.43346545,0.3178216,0.07783951,0.0031546466,0.038783118,0.0011173724,0.00042165333,0.0012020667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.19814068,0.4445513,0.25441676,0.0103929015,0.08826391,0.004234563],"domain_scores_gemma":[0.036628854,0.7654276,0.053375848,0.01924501,0.12261959,0.002703189],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.768357,0.0028848245,0.009539307,0.037041128,0.0059512383,0.033298872,0.011048585,0.017631574,0.0027669722],"category_scores_gemma":[0.88327223,0.005568037,0.010932583,0.028739296,0.016816515,0.029700762,0.018309323,0.023085006,0.0010253805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000811988,0.00022582643,0.006422117,0.40642416,0.0049390383,0.0008305211,0.025002895,0.0016269127,0.001245942,0.0319657,0.039027076,0.4814779],"study_design_scores_gemma":[0.0005673963,0.00039004165,0.005812604,0.8403488,0.0041330326,0.00051447755,0.006879738,0.001529134,0.0011479273,0.01941937,0.118929245,0.00032827904],"about_ca_topic_score_codex":0.008849178,"about_ca_topic_score_gemma":0.016178992,"teacher_disagreement_score":0.23164302,"about_ca_system_score_codex":0.041508593,"about_ca_system_score_gemma":0.12228079,"threshold_uncertainty_score":0.3011673},"labels":[],"label_agreement":null},{"id":"W4400974639","doi":"10.3390/jmahp12030014","title":"Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison","year":2024,"lang":"en","type":"article","venue":"Journal of Market Access & Health Policy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Steno Diabetes Center Copenhagen; Bayer","keywords":"Canagliflozin; Medicine; Internal medicine; Type 2 diabetes; Confounding; Hazard ratio; Randomized controlled trial; Kidney disease; Diabetes mellitus; Confidence interval; Endocrinology","score_opus":0.03849699808939505,"score_gpt":0.3778843863415415,"score_spread":0.3393873882521464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400974639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6565412,0.26096022,0.04541032,0.0022386387,0.0037999244,0.008169582,0.009008121,0.00035519619,0.013516764],"genre_scores_gemma":[0.9760908,0.007858641,0.01039165,0.00089291146,0.00033244953,0.0020328222,0.0014710668,0.000028379995,0.0009013001],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97525907,0.018540649,0.0023841343,0.0019374385,0.0014558537,0.0004229235],"domain_scores_gemma":[0.9813936,0.013979422,0.0022789633,0.001520636,0.000575239,0.0002521024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020492837,0.0018040051,0.0064774402,0.0017002578,0.0003392523,0.0019729168,0.0012739459,0.0019994597,0.0065152207],"category_scores_gemma":[0.04138315,0.0007506916,0.0152322175,0.0015234229,0.0007144402,0.0014866634,0.0017617138,0.0024151902,0.00035465774],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2998774,0.0012102763,0.023187015,0.045428395,0.5311071,0.0002275352,0.00044740314,0.0066331397,0.0016604955,0.004408919,0.0013187662,0.0844934],"study_design_scores_gemma":[0.122614525,0.029370183,0.03657702,0.004188367,0.7725508,0.00054699904,0.00031279234,0.010921618,0.0021333513,0.011314158,0.0092680715,0.00020215278],"about_ca_topic_score_codex":0.001870644,"about_ca_topic_score_gemma":0.0014807866,"teacher_disagreement_score":0.020492837,"about_ca_system_score_codex":0.00092163164,"about_ca_system_score_gemma":0.00081013754,"threshold_uncertainty_score":0.108377755},"labels":[],"label_agreement":null},{"id":"W4401858295","doi":"10.3390/jmahp12030017","title":"Patient Experience and Satisfaction with Orthopedic Services at a Community (Rural) Setting Hospital—How Is It Different from Urban Setting","year":2024,"lang":"en","type":"article","venue":"Journal of Market Access & Health Policy","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Patient satisfaction; Patient experience; Orthopedic surgery; Quality (philosophy); Health care; Work (physics); Medicine; Narrative; Nursing; Psychology","score_opus":0.044853196961646434,"score_gpt":0.4313270351385387,"score_spread":0.3864738381768923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401858295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8044709,0.1322821,0.001260128,0.03921749,0.0004696347,0.00007361633,0.000727518,0.000014517149,0.021484176],"genre_scores_gemma":[0.959946,0.03628534,0.00034282982,0.0025122114,0.00014188662,0.000031494732,0.00016805914,0.000004515525,0.000567743],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99722195,0.0017514033,0.00028095586,0.0001056725,0.0004041453,0.00023586651],"domain_scores_gemma":[0.99713147,0.0015116286,0.00068675407,0.000029702183,0.00038958932,0.00025083756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022902666,0.000073223484,0.00038892738,0.0005469548,0.00038686916,0.0018977842,0.00029177536,0.0005211105,0.0015127027],"category_scores_gemma":[0.007876938,0.00008345632,0.00043290932,0.001377259,0.0007318245,0.0011844661,0.0007394612,0.0006529039,0.00011076761],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090582826,0.00035529098,0.31982818,0.022787683,0.0013208607,0.002192301,0.083552405,0.0006166532,0.0013897408,0.020899653,0.02233401,0.5238175],"study_design_scores_gemma":[0.00008935804,0.0020581642,0.56553614,0.014631899,0.00073458476,0.0051109907,0.27009466,0.00068096066,0.0008665133,0.0056978245,0.13432363,0.00017518394],"about_ca_topic_score_codex":0.002356513,"about_ca_topic_score_gemma":0.0035513414,"teacher_disagreement_score":0.002356513,"about_ca_system_score_codex":0.00073637656,"about_ca_system_score_gemma":0.0011311823,"threshold_uncertainty_score":0.0121122},"labels":[],"label_agreement":null},{"id":"W4402185636","doi":"10.3390/jmahp12030020","title":"Non-Medical Switching or Discontinuation Patterns among Patients with Non-Valvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States: A Claims-Based Analysis","year":2024,"lang":"en","type":"article","venue":"Journal of Market Access & Health Policy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Discontinuation; Atrial fibrillation; Medicine; Internal medicine; Cardiology","score_opus":0.04110476782569135,"score_gpt":0.4063531100015693,"score_spread":0.365248342175878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402185636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99063045,0.00066750025,0.00011485606,0.00013882112,0.000013417837,0.000028140112,0.007830259,0.0000073616366,0.0005691245],"genre_scores_gemma":[0.9925362,0.00030045054,0.0001259045,0.00012568722,0.00002758608,0.00003812241,0.0066711954,0.000004595676,0.00017023298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984108,0.00032779173,0.00039153043,0.00035112663,0.00032233266,0.0001963084],"domain_scores_gemma":[0.9947208,0.0008646124,0.0031024101,0.00030135893,0.0005259453,0.00048495366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014274388,0.00029465836,0.0005634315,0.0014613402,0.0004613652,0.0009243403,0.0006058152,0.00054959365,0.001817514],"category_scores_gemma":[0.0045899623,0.0003238978,0.001408252,0.0026861504,0.00023084016,0.0007860632,0.0008345112,0.0011877714,0.00034683725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120392644,0.000038828675,0.9981969,0.00003188077,0.00015324983,0.000027850001,0.00007056504,0.000051610492,0.00003671418,0.000021378666,0.00039825912,0.0008523601],"study_design_scores_gemma":[0.000018204659,0.00006728839,0.9984493,0.00003650965,0.0000899655,0.00014101312,0.00023833451,0.0004966169,0.000028095807,0.000029771974,0.00039724278,0.000007737127],"about_ca_topic_score_codex":0.019406477,"about_ca_topic_score_gemma":0.021722758,"teacher_disagreement_score":0.019406477,"about_ca_system_score_codex":0.0006283389,"about_ca_system_score_gemma":0.00070813583,"threshold_uncertainty_score":0.038587034},"labels":[],"label_agreement":null},{"id":"W4412693204","doi":"10.3390/jmahp13030038","title":"Patient Involvement in Health Technology Assessments: Lessons for EU Joint Clinical Assessments","year":2025,"lang":"en","type":"review","venue":"Journal of Market Access & Health Policy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Agencia Española de Medicamentos y Productos Sanitarios; National Institute for Health and Care Excellence","keywords":"Health technology; European union; Best practice; Process (computing); Political science; Health care; Medicine; Process management; Public relations; Business; Knowledge management; Computer science; International trade","score_opus":0.7195339884714608,"score_gpt":0.6773990463529387,"score_spread":0.04213494211852209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412693204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012100306,0.91435266,0.0029311534,0.06960489,0.0014349967,0.00013084635,0.000059401547,0.00002418213,0.010251821],"genre_scores_gemma":[0.08442722,0.8364424,0.014970728,0.059265595,0.0016285259,0.0013632646,0.00024733262,0.00006622143,0.0015887021],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.87550527,0.09863702,0.010425511,0.0021301492,0.010518954,0.0027831192],"domain_scores_gemma":[0.8113952,0.16134466,0.008222685,0.00545723,0.010311782,0.0032684987],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13978921,0.00084510527,0.00273498,0.0022678508,0.0014323054,0.00878688,0.002813995,0.008638488,0.0032206804],"category_scores_gemma":[0.15490025,0.00064380036,0.002382567,0.006899426,0.004976243,0.012697129,0.011526167,0.010724594,0.0005367576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021309606,0.00015410615,0.0005607431,0.017719466,0.00030141976,0.00011932876,0.0026090331,0.0010556754,0.00009461682,0.16533068,0.018743621,0.79309815],"study_design_scores_gemma":[0.00044957577,0.0002729372,0.0027694097,0.105880424,0.0003875027,0.00034440722,0.0027656737,0.0004487404,0.00032907113,0.07803946,0.80825114,0.0000617142],"about_ca_topic_score_codex":0.0053695473,"about_ca_topic_score_gemma":0.004291251,"teacher_disagreement_score":0.8602108,"about_ca_system_score_codex":0.0076246695,"about_ca_system_score_gemma":0.03450939,"threshold_uncertainty_score":0.7392849},"labels":[],"label_agreement":null}]}